Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BISOPROLOL Cause Product availability issue? 10 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Product availability issue have been filed in association with BISOPROLOL (bisoprolol fumarate and hydrochlorothiazide). This represents 0.0% of all adverse event reports for BISOPROLOL.

10
Reports of Product availability issue with BISOPROLOL
0.0%
of all BISOPROLOL reports
3
Deaths
2
Hospitalizations

How Dangerous Is Product availability issue From BISOPROLOL?

Of the 10 reports, 3 (30.0%) resulted in death, 2 (20.0%) required hospitalization.

Is Product availability issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BISOPROLOL. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does BISOPROLOL Cause?

Dyspnoea (2,940) Bradycardia (2,535) Hypotension (2,504) Dizziness (2,153) Fall (2,011) Fatigue (1,983) Acute kidney injury (1,894) Malaise (1,602) Drug ineffective (1,486) Nausea (1,460)

What Other Drugs Cause Product availability issue?

RUXOLITINIB (2,142) LISDEXAMFETAMINE DIMESYLATE (1,530) CERTOLIZUMAB PEGOL (1,381) VEDOLIZUMAB (636) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610) METHYLPHENIDATE (444) SECUKINUMAB (399) BIMEKIZUMAB-BKZX (364) LACOSAMIDE (359) BRIVARACETAM (324)

Which BISOPROLOL Alternatives Have Lower Product availability issue Risk?

BISOPROLOL vs BISOPROLOL\BISOPROLOL BISOPROLOL vs BISOPROLOL\HYDROCHLOROTHIAZIDE BISOPROLOL vs BIVALIRUDIN BISOPROLOL vs BLEOMYCIN BISOPROLOL vs BLINATUMOMAB

Related Pages

BISOPROLOL Full Profile All Product availability issue Reports All Drugs Causing Product availability issue BISOPROLOL Demographics